Total Payments
$4,487
2024 Payments
$41.21
Companies
22
Transactions
241
Medicare Patients
515
Medicare Billing
$52,183
Payment Breakdown by Category
Food & Beverage$4,376 (97.5%)
Education$110.60 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,376 | 240 | 97.5% |
| Education | $110.60 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,716 | 96 | $0 (2023) |
| Novo Nordisk Inc | $447.15 | 26 | $0 (2021) |
| Merck Sharp & Dohme LLC | $428.98 | 20 | $0 (2024) |
| Amgen Inc. | $292.07 | 22 | $0 (2022) |
| Esperion Therapeutics, Inc. | $275.90 | 10 | $0 (2023) |
| Amarin Pharma Inc. | $245.45 | 17 | $0 (2022) |
| Medtronic Vascular, Inc. | $171.91 | 3 | $0 (2017) |
| Allergan Inc. | $167.02 | 8 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $149.88 | 10 | $0 (2022) |
| NESTLE HEALTHCARE NUTRITION INC. | $125.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41.21 | 2 | Merck Sharp & Dohme LLC ($41.21) |
| 2023 | $672.82 | 27 | Merck Sharp & Dohme LLC ($191.77) |
| 2022 | $294.29 | 16 | Merck Sharp & Dohme LLC ($113.67) |
| 2021 | $621.02 | 31 | Esperion Therapeutics, Inc. ($193.79) |
| 2020 | $540.64 | 31 | Novo Nordisk Inc ($235.84) |
| 2019 | $540.04 | 35 | Novartis Pharmaceuticals Corporation ($255.07) |
| 2018 | $782.35 | 50 | Novartis Pharmaceuticals Corporation ($420.01) |
| 2017 | $994.20 | 49 | Novartis Pharmaceuticals Corporation ($488.97) |
All Payment Transactions
241 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/01/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/25/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/01/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/17/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/12/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/12/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/24/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/17/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/15/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/13/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $76.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/05/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/31/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $15.53 | General |
| Category: Cardiovascular Device | ||||||
| 03/27/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/15/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/08/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/01/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 82 | 226 | $35,178 | $10,068 |
| 2022 | 3 | 89 | 258 | $39,588 | $11,265 |
| 2021 | 5 | 172 | 391 | $53,991 | $15,684 |
| 2020 | 4 | 172 | 424 | $57,916 | $15,167 |
Total Patients
515
Total Services
1,299
Medicare Billing
$52,183
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 102 | $21,930 | $8,322 | 37.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 36 | 108 | $9,504 | $1,064 | 11.2% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 12 | 16 | $3,744 | $682.24 | 18.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 118 | $25,370 | $9,436 | 37.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 40 | 127 | $11,176 | $1,245 | 11.1% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2022 | 11 | 13 | $3,042 | $584.47 | 19.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 140 | $30,100 | $12,047 | 40.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 42 | 146 | $12,848 | $1,525 | 11.9% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2021 | 12 | 18 | $4,554 | $964.22 | 21.2% |
| 93288 | Evaluation of parameters of leadless, single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report | Office | 2021 | 13 | 18 | $4,212 | $720.40 | 17.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 64 | 69 | $2,277 | $427.05 | 18.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 167 | $35,905 | $12,009 | 33.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 55 | 182 | $16,016 | $2,129 | 13.3% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2020 | 13 | 16 | $4,048 | $682.86 | 16.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 50 | 59 | $1,947 | $345.50 | 17.7% |
About Dr. Bertram Johnson, MD
Dr. Bertram Johnson, MD is a Specialist healthcare provider based in Lancaster, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477588218.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bertram Johnson, MD has received a total of $4,487 in payments from pharmaceutical and medical device companies, with $41.21 received in 2024. These payments were reported across 241 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,376).
As a Medicare-enrolled provider, Johnson has provided services to 515 Medicare beneficiaries, totaling 1,299 services with total Medicare billing of $52,183. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Cardiovascular Disease
- Location Lancaster, PA
- Active Since 07/11/2006
- Last Updated 02/05/2018
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477588218
Products in Payments
- ENTRESTO (Drug) $1,598
- VERQUVO (Drug) $428.98
- Vascepa (Drug) $245.45
- Ozempic (Drug) $243.42
- Repatha (Biological) $218.71
- BYSTOLIC (Drug) $165.02
- NEXLETOL (Drug) $155.88
- RYBELSUS (Drug) $125.00
- ZENPEP (Drug) $125.00
- NEXLIZET (Drug) $120.02
- LEQVIO (Drug) $118.56
- Advisa (Device) $114.10
- JARDIANCE (Drug) $113.24
- Victoza (Drug) $78.73
- Corlanor (Drug) $73.36
- ELIQUIS (Drug) $64.73
- Micra (Device) $57.81
- BRILINTA (Drug) $56.41
- MULTAQ (Drug) $52.28
- Livalo (Drug) $49.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Lancaster
Dr. Marites Del Rosario, M.d, M.D
Specialist — Payments: $11,424
Specialist $11,424
Dr. Sameh Gadallah, M.d, M.D
Specialist — Payments: $11,062
Specialist $11,062
Adam Hyatt, M.d, M.D
Specialist — Payments: $7,458
Specialist $7,458
Dr. Pramod Kadambi, M.d, M.D
Specialist — Payments: $4,441
Specialist $4,441
Ira Opatowsky, Md, MD
Specialist — Payments: $2,407
Specialist $2,407
Dr. Dennis Latuno, M.d, M.D
Specialist — Payments: $2,225
Specialist $2,225